Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.
Kümpfel T, Giglhuber K, Aktas O, Ayzenberg I, Bellmann-Strobl J, Häußler V, Havla J, Hellwig K, Hümmert MW, Jarius S, Kleiter I, Klotz L, Krumbholz M, Paul F, Ringelstein M, Ruprecht K, Senel M, Stellmann JP, Bergh FT, Trebst C, Tumani H, Warnke C, Wildemann B, Berthele A; Neuromyelitis Optica Study Group (NEMOS). Kümpfel T, et al. J Neurol. 2024 Apr 5. doi: 10.1007/s00415-024-12288-2. Online ahead of print. J Neurol. 2024. PMID: 38578500 No abstract available.
Risk factors for intracerebral hemorrhage in small-vessel disease and non-small-vessel disease etiologies-an observational proof-of-concept study.
Arndt P, Chahem C, Luchtmann M, Kuschel JN, Behme D, Pfister M, Neumann J, Görtler M, Dörner M, Pawlitzki M, Jansen R, Meuth SG, Vielhaber S, Henneicke S, Schreiber S. Arndt P, et al. Among authors: pawlitzki m. Front Neurol. 2024 Mar 7;15:1322442. doi: 10.3389/fneur.2024.1322442. eCollection 2024. Front Neurol. 2024. PMID: 38515448 Free PMC article.
Ravulizumab in myasthenic crisis: the first case report.
Konen FF, Jendretzky KF, Ratuszny D, Schuppner R, Sühs KW, Pawlitzki M, Ruck T, Meuth SG, Skripuletz T. Konen FF, et al. Among authors: pawlitzki m. J Neurol. 2024 May;271(5):2898-2901. doi: 10.1007/s00415-024-12234-2. Epub 2024 Feb 23. J Neurol. 2024. PMID: 38388927 Free PMC article. No abstract available.
The Use of Nitrosative Stress Molecules as Potential Diagnostic Biomarkers in Multiple Sclerosis.
Räuber S, Förster M, Schüller J, Willison A, Golombeck KS, Schroeter CB, Oeztuerk M, Jansen R, Huntemann N, Nelke C, Korsen M, Fischer K, Kerkhoff R, Leven Y, Kirschner P, Kölsche T, Nikolov P, Mehsin M, Marae G, Kokott A, Pul D, Schulten J, Vogel N, Ingwersen J, Ruck T, Pawlitzki M, Meuth SG, Melzer N, Kremer D. Räuber S, et al. Among authors: pawlitzki m. Int J Mol Sci. 2024 Jan 8;25(2):787. doi: 10.3390/ijms25020787. Int J Mol Sci. 2024. PMID: 38255863 Free PMC article.
SARS-CoV-2 Vaccination and Neuroimmunological Disease: A Review.
Willison AG, Pawlitzki M, Lunn MP, Willison HJ, Hartung HP, Meuth SG. Willison AG, et al. Among authors: pawlitzki m. JAMA Neurol. 2024 Feb 1;81(2):179-186. doi: 10.1001/jamaneurol.2023.5208. JAMA Neurol. 2024. PMID: 38227318 Review.
Guideline for the management of myasthenic syndromes.
Wiendl H, Abicht A, Chan A, Della Marina A, Hagenacker T, Hekmat K, Hoffmann S, Hoffmann HS, Jander S, Keller C, Marx A, Melms A, Melzer N, Müller-Felber W, Pawlitzki M, Rückert JC, Schneider-Gold C, Schoser B, Schreiner B, Schroeter M, Schubert B, Sieb JP, Zimprich F, Meisel A. Wiendl H, et al. Among authors: pawlitzki m. Ther Adv Neurol Disord. 2023 Dec 26;16:17562864231213240. doi: 10.1177/17562864231213240. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 38152089 Free PMC article. Review.
Chronic Fatigue and Dysautonomia following COVID-19 Vaccination Is Distinguished from Normal Vaccination Response by Altered Blood Markers.
Semmler A, Mundorf AK, Kuechler AS, Schulze-Bosse K, Heidecke H, Schulze-Forster K, Schott M, Uhrberg M, Weinhold S, Lackner KJ, Pawlitzki M, Meuth SG, Boege F, Ruhrländer J. Semmler A, et al. Among authors: pawlitzki m. Vaccines (Basel). 2023 Oct 26;11(11):1642. doi: 10.3390/vaccines11111642. Vaccines (Basel). 2023. PMID: 38005974 Free PMC article.
K2P2.1 is a regulator of inflammatory cell responses in idiopathic inflammatory myopathies.
Nelke C, Müntefering T, Cengiz D, Theissen L, Dobelmann V, Schroeter CB, Block H, Preuße C, Michels APE, Lichtenberg S, Pawlitzki M, Pfeuffer S, Huntemann N, Zarbock A, Briese T, Kittl C, Dittmayer C, Budde T, Lundberg IE, Stenzel W, Meuth SG, Ruck T. Nelke C, et al. Among authors: pawlitzki m. J Autoimmun. 2024 Jan;142:103136. doi: 10.1016/j.jaut.2023.103136. Epub 2023 Nov 5. J Autoimmun. 2024. PMID: 37935063 Free article.
88 results